Overview

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis

Status:
Terminated

Trial end date:
2020-06-15

Target enrollment:

Participant gender:

Summary

This is a double-blind study to evaluate the efficacy and safety of FX006 in patients with glenohumeral osteoarthritis (OA) or shoulder adhesive capsulitis (AC).

Phase:

Phase 2

Details

Lead Sponsor:

Flexion Therapeutics, Inc.

Collaborator:

Medpace, Inc.

Treatments:

FX006